The DESyne BDS drug-eluting stent achieved a 1.0% target lesion failure rate compared to 8.2% by the durable polymer drug-eluting stent.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,